Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label changed from v3.6.2 to v3.6.3, signaling a system or UI update. No study content, eligibility criteria, or results were altered.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, signaling an update to the study record since the prior version.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page’s Study Details metadata and labels have been updated to include the investigator’s name and verification status, and to standardize the treatment-related heading.SummaryDifference2%

- Check39 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, representing a minor page refresh with no change to the study details.SummaryDifference0.1%

- Check60 days agoChange DetectedThe footer now shows Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a small platform update rather than any modification to the study details on the page.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s displayed software revision has been updated to the next release (from v3.5.2 to v3.5.3), indicating a backend/site version change rather than an update to the clinical trial details.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.